STUDY TO FIND OUT THE EFFECT OF HOMOEOPATHIC MEDICINE IN REDUCING ANTIBODY LEVELS IN AUTO IMMUNE THYROIDITIS

AN OPEN LABEL CLINICAL INTERVENTIONAL TRIAL TO FIND OUT THE EFFICACY OF HOMOEOPATHIC MEDICINES IN REDUCING ANTIBODY LEVELS IN AUTOIMMUNE THYROIDITIS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021858

Enrollment

Registered

2019-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E063- Autoimmune thyroiditis

Interventions

Intervention1: Homoeopathic medicines: Individualised homoeopathic medicines as per homoeopathic principles Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients with either ATPO above 35 IU/ml or Anti Tg above 20IU/ml or Thyroid-stimulating hormone (TSH) receptor binding inhibitor immunoglobulin (TBII)/ TRAb more than 1.75 IU/L

Exclusion criteria

Exclusion criteria: Hypothyroidism associated with thyroid malignancies Patients with other severe systemic illness like uncontrolled diabetes, malignant hypertension, other malignancies etc. Immuno compromised patients Pregnant ladies and lactating mothers

Design outcomes

Primary

Measure	Time frame
Reduction in antibody levels in Auto Immune Thyroiditis after Homoeopathic InterventionTimepoint: 1 year follow up	—

Secondary

Measure	Time frame
Homoeopathic medicines are effective in Auto Immune ThyroiditisTimepoint: 1 year follow up	—

Countries

India

Contacts

Public ContactVISHNUPRIYA S V

NATIONAL HOMOEOPATHY RESEARCH INSTITUTE IN MENTAL HEALTH

drbinurajsr@gmail.com09446106525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026